FTSV - Forty Seven Inc
Previous close
95.51
0 0%
Share volume: 0
Last Updated: Mon 06 Apr 2020 06:00:00 AM CEST
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$95.51
0.00
0.00%
Summary score
30%
Profitability
28%
Dept financing
21%
Liquidity
41%
Performance
32%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.97%
Return on assets
-15.67%
Return on sales
0%
Return on invested capital
161.19%
Total debt ratio
14.54%
Debt ratio change over timeo
-0.91%
Current Ratio
8.26%
Quick Ratio
0%
Cash Position Ratio
2.15%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.9%
Return on assets
-14.35%
Return on sales
0%
Return on invested capital
151.73%
Total debt ratio
13.9%
Debt ratio change over timeo
-0.91%
Current Ratio
8.83%
Quick Ratio
0%
Cash Position Ratio
3.13%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-8.25%
Return on assets
-7.99%
Return on sales
0%
Return on invested capital
156.86%
Total debt ratio
7.47%
Debt ratio change over time
-0.91%
Current Ratio
14.81%
Quick Ratio
0%
Cash Position Ratio
9.38%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-111.52%
Return on assets
-110.14%
Return on sales
0%
Return on invested capital
14.79%
Total debt ratio
-90.79%
Debt ratio change over time
-0.91%
Current Ratio
5.31%
Quick Ratio
0%
Cash Position Ratio
1.11%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FTSV | PRNB | RARX | GCVRZ |
|---|---|---|---|---|
| Return on equity | -17.97% | -4.62% | -14.58% | 0% |
| Return on assets | -15.67% | -1.76% | -13.27% | 0% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 161.19% | -572.22% | 733.8% | 0% |
| Profitability | 30% | 0% | 25% | 50% |
| Total debt ratio | 14.54% | 30.12% | 9.46% | 0% |
| Debt ratio change over time | -0.91% | -0.99% | -1% | 0% |
| Dept financing | 12% | 25% | 8% | 25% |
| Current Ratio | 8.83% | 14.71% | 18.98% | 0% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 3.13% | 2.25% | 18.46% | 0% |
| Liquididy | 42% | 22% | 50% | 0% |
| Short-term ratios | FTSV | PRNB | RARX | GCVRZ |
|---|---|---|---|---|
| Return on equity | -15.9% | -6.5% | -11.27% | 0% |
| Return on assets | -14.35% | -6.38% | -10.92% | 0% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 151.73% | -657.59% | 2762.38% | 0% |
| Profitability | 26% | 0% | 25% | 50% |
| Total debt ratio | 13.9% | 10.19% | 6.91% | 0% |
| Debt ratio change over time | -0.91% | -0.99% | -0.99% | 0% |
| Dept financing | 25% | 18% | 12% | 25% |
| Current Ratio | 8.83% | 14.71% | 18.98% | 0% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 3.13% | 2.25% | 18.46% | 0% |
| Liquididy | 41% | 22% | 50% | 0% |